The legacy of Sildenafil offers a complicated case study for stakeholders eyeing pharma. While first sales were remarkable, current patent lapse and the rise of cheaper versions have significantly influenced revenues. Moreover, increasing regulatory scrutiny and demands to decrease prescription p

The emergence of so-called "Elite Gambler's Viagra" – often referring to exceptionally high doses administered by unscrupulous physicians – represents a troublingly alarming trend. While common dosages of Viagra are intended for treating erectile dysfunction safely in most individuals, these sign